相关实验视频
Updated: Jun 24, 2025
05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
550
[初级脏三倍表达体DLBCL在持续血液透析和过支持下接受化疗]
Kohei Watanabe1, Naonori Harada2, Ikumi Shibano2
1Junior Resident, Fuchu Hospital.
概括
一种罕见的原发性脏扩散性大B细胞淋巴瘤 (DLBCL) 被成功治疗. 连续血液过 (CHDF) 与R-CHOP化疗相结合,导致完整的反应,改善功能.
科学领域:
- 在瘤学瘤学.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 血液学 血液学 血液学
背景情况:
- 原发性淋巴瘤异常罕见,具有诊断和治疗方面的挑战.
- 一名69岁的女性出现了暗示炎炎的症状,但对抗生素反应有限.
- 图像检测显示异质性功能增强和可溶性IL-2受体水平升高,促使进一步调查.
研究的目的:
- 报告一种罕见的初级脏扩散性大B细胞淋巴瘤 (DLBCL) 病例.
- 要突出成功的管理策略,包括结合连续血液过 (CHDF) 和化疗.
- 强调在具有挑战性的病例中实现完全缓解的潜力.
主要方法:
- 透皮脏活检证实了淋巴瘤细胞透.
- 免疫组织化学染色发现MYC/BCL2/BCL6阳性,诊断出三重表达体DLBCL.
- 治疗涉及持续血液过 (CHDF) 治疗急性损伤,随后进行R-CHOP化疗.
主要成果:
- 这名患者被诊断为IVB阶段的原发性三次表达体DLBCL.
- 由于急性损伤,启动了连续血液过 (CHDF).
- 在六轮R-CHOP化疗后,获得了完全反应和功能快速改善.
结论:
- 初级脏DLBCL是一种罕见的实体,需要专门的诊断和治疗方法.
- 结合CHDF和R-CHOP化疗可以有效地管理原发性性DLBCL,即使最初的预后不佳.
- 这一案例强调了考虑罕见诊断和采用多模式治疗策略以获得最佳患者结果的重要性.
更多相关视频
07:11Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
Published on: July 19, 2018
15.3K
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.5K
相关概念视频
01:27Dialysis
293
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
293
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K